Back to Results
First PageMeta Content
Vaccine / Adjuvant / Agenus / Heat shock protein / Vaccination / Biology / CD134


Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications
Add to Reading List

Document Date: 2014-04-16 12:35:04

Open Document

File Size: 32,41 KB

Share Result on Facebook

City

LEXINGTON / /

Company

IgG / GlaxoSmithKline / Agenus Inc. / Janssen / /

/

Event

FDA Phase / /

MedicalCondition

cancer / infectious disease / /

/

Position

Jonae R. Barnes Vice President Investor Relations and Corporate Communications jonae.barnes@agenusbio.com / /

Product

QS-21 Stimulon / Retrocyte Display / Stimulon® / /

ProvinceOrState

Massachusetts / /

URL

www.virtualshareholdermeeting.com/Agenus2014 / www.agenusbio.com / www.agenusbio.com/webcast / /

SocialTag